$3.16
0.5822.48%
At close: -
$3.32
0.165.06%
After Hours: 7:58 PM EDT
Sonoma Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sonoma Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.59 | $-1.00 | 41.0 % |
Jun 2024 | 2024-08-08 | $-1.40 | $-1.20 | -16.7 % |
Sep 2023 | 2023-11-13 | $-5.80 | $-4.80 | -20.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $3.58M | $3.98M | -10.1 % |
Jun 2024 | 2024-08-08 | $3.39M | $3.94M | -13.9 % |
Mar 2024 | 2024-06-17 | $3.44M | $3.98M | -13.6 % |
Sep 2023 | 2023-11-13 | $2.73M | $3.48M | -21.5 % |
Sonoma Pharmaceuticals (SNOA) is scheduled to report earnings on February 6, 2025. The last reported earnings were for reported on November 7, 2024 for Q2.
The Actual EPS was $-0.59, which beat the estimate of $-1.00.
The Actual Revenue was $3.6M, which missed the estimate of $4M.
Browse earnings estimates, EPS, and revenue on all stocks.